Global Acromegaly Market
Healthcare Services

Understanding the Acromegaly Market’s Growth Prospects from 2024 to 2033

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Acromegaly Market from 2024 to 2033?

The acromegaly market has grown rapidly in recent years. It is expected to grow from $1.79 billion in 2023 to $2.15 billion in 2024, reflecting a compound annual growth rate (CAGR) of 19.8%. This growth is driven by the increasing prevalence of acromegaly, greater awareness, government initiatives, and the demand for effective treatments.

The acromegaly market is expected to grow rapidly, reaching $4.17 billion by 2028, with a CAGR of 18.1%. The growth is fueled by investments in research, a rising number of screening programs, increasing healthcare spending, and a demand for minimally invasive treatments. Trends include innovative treatments, the development of targeted therapies, a strong drug pipeline, and advancements in personalized medicine.

Claim Your Free Sample of the Global Acromegaly Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12913&type=smp

The increasing number of hormonal diseases, particularly diabetes, is anticipated to drive the acromegaly market’s growth. Hormonal diseases, including acromegaly, arise due to hormonal imbalances, often involving excessive growth hormone or cortisol production. The connection between acromegaly and insulin resistance or type 2 diabetes mellitus, with about 50% of acromegaly patients affected, highlights the growing impact. In 2021, diabetes affected 537 million adults worldwide, with projections to reach 643 million by 2030 and 783 million by 2045, according to the International Diabetes Federation. This rising incidence of hormonal diseases is fueling the acromegaly market’s expansion.

1) By Type: Ectopic Acromegaly, Acromegaly Due To Growth Hormone

2) By Diagnosis: GH And IGF-I Measurement, Growth Hormone Suppression Test, Imaging, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Treatment: Medication, Somatostatin analogues, Dopamine Agonists, Growth Hormone Antagonist, Surgery, Radiation, Other Treatments

5) By End Users: Hospitals, Specialty Clinics, Homecare, Other End Users

In the acromegaly market, companies are focusing on innovative products like generic lanreotide to stay competitive. In July 2021, Advanz Pharma Corp. launched Mytolac (lanreotide) in Germany, the first generic lanreotide for treating acromegaly and certain gastroenteropancreatic neuroendocrine tumors. Lanreotide is recommended for patients with abnormal circulating growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels after other treatments.

Order Now for Fast Delivery of Your Acromegaly Market Report!

https://www.thebusinessresearchcompany.com/report/acromegaly-global-market-report

North America was the largest region in the next generation computing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation computing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Acromegaly Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the acromegaly market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Acromegaly Market Include
1. Acromegaly Market Executive Summary
2. Acromegaly Market Segments
3. Acromegaly Market Size And Template Market Growth Rate
4. Key Acromegaly Market Trends
5. Major Acromegaly Market Drivers
……
25. Key Mergers And Acquisitions In The Acromegaly Market
26. Top Acromegaly Companies
27. Acromegaly Market Opportunities And Strategies
28. Acromegaly Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:

Generic Central Nervous System Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generic-central-nervous-system-drugs-global-market-report

Nerve Repair And Regenerative Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report

Central Nervous System Biomarkers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/central-nervous-system-biomarkers-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: